Literature DB >> 7041308

Pharmacokinetics of topically applied ophthalmic drugs.

J W Shell.   

Abstract

Pharmacokinetic applications in recent years have led to significant advances in systemic drug therapy, but applications to topical, ophthalmic therapy have been far less numerous. Pharmacokinetics is the study of the time course of the absorption, distribution, metabolism, and elimination of an administered drug. Thus, it includes the quantitation of such elements of drug bioavailability as tear dilution, drug binding, and vehicle effects; factors affecting corneal absorption and subsequent tissue distribution; dosage form effects; and pathways of elimination. These factors are important because they significantly influence the clinical responses to administered drugs, in some instances to a profound degree. These elements and their clinical implications are discussed along with some recent applications, exemplified with data from studies on frequently prescribed drugs.

Mesh:

Substances:

Year:  1982        PMID: 7041308     DOI: 10.1016/0039-6257(82)90081-9

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  49 in total

1.  Effect on mydriasis of modifying the volume of phenylephrine drops.

Authors:  E W Craig; P G Griffiths
Journal:  Br J Ophthalmol       Date:  1991-04       Impact factor: 4.638

2.  Syncope and falls due to timolol eye drops.

Authors:  Marije E Müller; Nathalie van der Velde; Jaap W M Krulder; Tischa J M van der Cammen
Journal:  BMJ       Date:  2006-04-22

3.  Drop sizes of commonly used topical beta blockers.

Authors:  P G Griffiths; R J Stirling
Journal:  Br J Ophthalmol       Date:  1991-02       Impact factor: 4.638

4.  Evaluation of mucoadhesive polymers in ocular drug delivery. I. Viscous solutions.

Authors:  N M Davies; S J Farr; J Hadgraft; I W Kellaway
Journal:  Pharm Res       Date:  1991-08       Impact factor: 4.200

Review 5.  Safety considerations in treating concomitant diseases in patients with asthma.

Authors:  L W Hunt
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

Review 6.  Ocular drug delivery. Pharmacokinetic considerations.

Authors:  R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

7.  Effects of adrenergic and cholinergic antagonists on diameter of nasolacrimal drainage system.

Authors:  Junji Narioka; Yuichi Ohashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-06-20       Impact factor: 3.117

8.  Dexamethasone diffusion across contact lenses is inhibited by Staphylococcus epidermidis biofilms in vitro.

Authors:  Kimberly M Brothers; Amy C Nau; Eric G Romanowski; Robert M Q Shanks
Journal:  Cornea       Date:  2014-10       Impact factor: 2.651

9.  Assessment of bronchial effects following topical administration of butylamino-phenoxy-propanol-acetate, an oculoselective beta-adrenoceptor blocker in asthmatic subjects.

Authors:  K G Bauer; F Brunner-Ferber; L M Distlerath; E A Lippa; B Binkowitz; P Till; G A Kaik
Journal:  Br J Clin Pharmacol       Date:  1992-08       Impact factor: 4.335

10.  Effect of dexamethasone 0.1% and prednisolone acetate 1.0% eye drops on the blood-aqueous barrier after cataract surgery: a controlled randomized fluorophotometric study.

Authors:  M Diestelhorst; F Aspacher; W Konen; G K Krieglstein; R D Hilgers
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.